A QTc study of cabazitaxel in patients with advanced solid tumors

被引:0
|
作者
Wade, James Lloyd
Dakhil, Shaker R.
Baron, Ari David
Rottey, Sylvie
Millard, Frederick E.
Daugaard, Gedske
Machiels, Jean-Pascal H.
Conkright, William A.
Sharma, Sunil
Soetekouw, Patricia M. M. B.
Yachnin, Jeffrey
Sengelov, Lisa
van Veldhuizen, Peter
Agarwala, Sanjiv S.
Nguyen, T. X. Quyen
Chadjaa, Mustapha
Maison-Blanche, Pierre
机构
[1] Canc Care Specialists Cent Illinois, Decatur, IL USA
[2] Canc Ctr Kansas, Wichita, KS USA
[3] Calif Pacific Med Ctr, San Francisco, CA USA
[4] Ghent Univ Hosp, Ghent, Belgium
[5] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[6] Rigshosp, DK-2100 Copenhagen, Denmark
[7] Catholic Univ Louvain, Ctr Canc, B-1200 Brussels, Belgium
[8] Purchase Canc Grp, Paducah, KY USA
[9] Huntsman Canc Inst, Salt Lake City, UT USA
[10] Univ Hosp Maastricht, Maastricht, Netherlands
[11] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden
[12] Herlev Hosp, DK-2730 Herlev, Denmark
[13] Kansas City Vet Adm Med Ctr, Kansas City, MO USA
[14] St Lukes Canc Ctr, Bethlehem, PA USA
[15] Sanofi, Paris, France
[16] Hop Lariboisiere, F-75475 Paris, France
关键词
D O I
10.1200/jco.2012.30.5_suppl.257
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
257
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A QTc study of cabazitaxel in patients with advanced solid tumors.
    Wade, James Lloyd
    Dakhil, Shaker R.
    Baron, Ari David
    Rottey, Sylvie
    Millard, Frederick E.
    Daugaard, Gedske
    Machiels, Jean-Pascal H.
    Conkright, William A.
    Sharma, Sunil
    Soetekouw, Patricia M. M. B.
    Yachnin, Jeffrey
    Sengelov, Lisa
    van Veldhuizen, Peter
    Agarwala, Sanjiv S.
    Nguyen, T. X. Quyen
    Chadjaa, Mustapha
    Maison-Blanche, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors
    Ferron, Geraldine M.
    Dai, Yang
    Semiond, Dorothee
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 681 - 692
  • [3] Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors
    Géraldine M. Ferron
    Yang Dai
    Dorothée Semiond
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 681 - 692
  • [4] A phase I QTc study of tivozanib in patients with advanced solid tumors.
    Chadha, Manpreet Kaur
    Infante, Jeffrey R.
    Cotreau, Monette M.
    Jacobson, Lindsey
    Strahs, Andrew Louis
    Slichenmyer, William
    Vargo, Dennis
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [5] Cabazitaxel plus cisplatin coadministration and drug-interaction study in patients with advanced solid tumors
    Mita, Alain C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Mahalingam, Devalingam
    Tan, Benjamin R.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Lockhart, Albert C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
    Pierre Maison-Blanche
    Shaker Dakhil
    Ari Baron
    Sylvie Rottey
    Fred Millard
    Gedske Daugaard
    Jean-Pascal Machiels
    William Conkright
    Sunil Sharma
    Patricia M. M. B. Soetekouw
    Jeffrey Yachnin
    Lisa Sengeløv
    Peter Van Veldhuizen
    Sanjiv S. Agarwala
    Dorothée Sémiond
    Mustapha Chadjaa
    Liji Shen
    James L. Wade
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1241 - 1252
  • [7] An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
    Maison-Blanche, Pierre
    Dakhil, Shaker
    Baron, Ari
    Rottey, Sylvie
    Millard, Fred
    Daugaard, Gedske
    Machiels, Jean-Pascal
    Conkright, William
    Sharma, Sunil
    Soetekouw, Patricia M. M. B.
    Yachnin, Jeffrey
    Sengelov, Lisa
    Van Veldhuizen, Peter
    Agarwala, Sanjiv S.
    Semiond, Dorothee
    Chadjaa, Mustapha
    Shen, Liji
    Wade, James L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) : 1241 - 1252
  • [8] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [9] Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors
    A. Craig Lockhart
    Shankar Sundaram
    John Sarantopoulos
    Monica M. Mita
    Andrea Wang-Gillam
    Jennifer L. Moseley
    Stephanie L. Barber
    Alex R. Lane
    Claudine Wack
    Laurent Kassalow
    Jean-François Dedieu
    Alain C. Mita
    Investigational New Drugs, 2014, 32 : 1236 - 1245
  • [10] Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors
    Lockhart, A. Craig
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Wang-Gillam, Andrea
    Moseley, Jennifer L.
    Barber, Stephanie L.
    Lane, Alex R.
    Wack, Claudine
    Kassalow, Laurent
    Dedieu, Jean-Francois
    Mita, Alain C.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (06) : 1236 - 1245